ArticleCurrent oncology (Toronto, Ont.)2025
Venetoclax Plus CyBorD Induction Therapy and Venetoclax Maintenance Treatment for Immunoglobulin Light Chain Amyloidosis with t(11;14) Translocation.
Gréta Garami et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.